Award
National Institute on Drug Abuse 11567759
Hemp-derived Cannabidiol for the treatment of cannabis use disorder in concentrate users: A double-blind placebo-controlled randomized trial
Recipient
Not specified
Award Amount
$98,952.00
Ceiling
$98,952.00
Awarded
August 05, 2026
Identifier
11567759
This award funds a clinical trial testing hemp-derived cannabidiol as a treatment for cannabis use disorder in concentrate users, involving 150 adults and psychological support, aiming to reduce THC exposure and symptoms.
Description
A randomized controlled trial with 150 adult participants to evaluate hemp-derived cannabidiol for treating cannabis use disorder in concentrate users. Participants receive psychological intervention support. Primary outcomes include reduction in THC exposure, CUD symptoms, and withdrawal symptoms.